MedTrace Logo

Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups

NCT00004781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES: I. Evaluate the development of oral manifestations of human immunodeficiency virus infection in relationship to the onset of immunologic alterations and systemic symptoms in different risk groups: gay/bisexual men, male intravenous drug users, and female intravenous drug users.

II. Evaluate the immune and inflammatory response to periodontal and other microbial pathogens.

III. Evaluate the bacterial species infecting the oral cavity in patients in these risk groups.

Conditions

  • HIV Infections
  • Candidiasis, Oral

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • National Institute of Dental and Craniofacial Research (NIDCR)

    lead NIH

Principal Investigators

  • Ira B. Lamster · Columbia University

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1989-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004781 on ClinicalTrials.gov